Vincenzo Mazzaferro Selected Research

basalt

1/2022	Migration rate using fully covered metal stent in anastomotic strictures after liver transplantation: Results from the BASALT study group.
1/2017	Management of biliary anastomotic strictures after liver transplantation (BASALT study): A nationwide Italian survey.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vincenzo Mazzaferro Research Topics

Disease

81	Hepatocellular Carcinoma (Hepatoma) 02/2022 - 11/2004
70	Neoplasms (Cancer) 02/2022 - 05/2002
16	Neoplasm Metastasis (Metastasis) 12/2021 - 08/2003
15	Fibrosis (Cirrhosis) 01/2019 - 01/2004
14	Neuroendocrine Tumors (Neuroendocrine Tumor) 12/2021 - 10/2007
10	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 08/2003
7	Cholangiocarcinoma 10/2022 - 01/2016
7	Liver Failure 10/2021 - 06/2002
6	End Stage Liver Disease 01/2021 - 01/2016
6	Infections 01/2018 - 04/2007
5	Disease Progression 12/2021 - 01/2010
5	Fistula 01/2021 - 05/2006
5	Liver Diseases (Liver Disease) 01/2021 - 01/2010
4	Stomach Neoplasms (Stomach Cancer) 05/2022 - 12/2011
4	Thrombosis (Thrombus) 12/2020 - 05/2013
4	Liver Neoplasms (Liver Cancer) 01/2018 - 12/2008
3	Pathologic Constriction (Stenosis) 01/2022 - 01/2017
3	Ascites 01/2021 - 09/2002
3	Portal Hypertension 02/2017 - 01/2016
3	Hepatitis B 05/2010 - 05/2005
2	Carcinoid Tumor (Carcinoid) 01/2020 - 01/2015
2	Diarrhea 12/2019 - 07/2008
2	Fatigue 11/2019 - 10/2015
2	Primitive Neuroectodermal Tumors (PNET) 01/2019 - 01/2018
2	Necrosis 01/2018 - 10/2009
2	Sepsis (Septicemia) 01/2018 - 05/2010
2	Hepatitis C 02/2017 - 06/2012
2	Weight Loss (Weight Reduction) 01/2016 - 07/2008
2	Inflammation (Inflammations) 04/2015 - 04/2013
2	Carcinoma (Carcinomatosis) 10/2003 - 09/2002
2	Insulin Resistance 08/2003 - 09/2002
2	Liver Cirrhosis (Hepatic Cirrhosis) 08/2003 - 09/2002

Drug/Important Bio-Agent (IBA)

14	Sorafenib (BAY 43-9006)FDA Link 12/2021 - 07/2008
10	Pharmaceutical PreparationsIBA 01/2022 - 09/2002
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2007
6	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2020 - 04/2007
5	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 09/2021 - 01/2015
5	Biological ProductsIBA 01/2021 - 03/2004
5	Sirolimus (Rapamycin)FDA Link 11/2020 - 12/2008
4	RNA (Ribonucleic Acid)IBA 01/2022 - 03/2006
4	CytokinesIBA 01/2022 - 05/2005
4	BilirubinIBA 01/2021 - 05/2012
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2004
4	Octreotide (Sandostatin)FDA LinkGeneric 01/2020 - 05/2016
4	Everolimus FDA Link 01/2019 - 12/2008
3	lanreotide (Somatuline)FDA Link 12/2021 - 01/2018
3	Metformin (Glucophage)FDA LinkGeneric 12/2021 - 05/2016
3	regorafenibIBA 12/2021 - 11/2013
3	InterferonsIBA 01/2021 - 12/2006
3	TOR Serine-Threonine KinasesIBA 11/2020 - 05/2010
3	ParaffinIBA 08/2019 - 11/2008
3	Bevacizumab (Avastin)FDA Link 01/2019 - 07/2015
3	Messenger RNA (mRNA)IBA 01/2019 - 09/2012
3	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 08/2003
3	Cetuximab (Erbitux)FDA Link 01/2018 - 07/2015
3	Yttrium-90IBA 01/2018 - 05/2013
3	Insulin (Novolin)FDA Link 05/2016 - 09/2002
3	MicroRNAs (MicroRNA)IBA 09/2012 - 01/2010
2	PlasticsIBA 01/2022 - 01/2019
2	MetalsIBA 01/2022 - 01/2019
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2020
2	basaltIBA 01/2022 - 01/2017
2	Somatostatin Receptors (Somatostatin Receptor)IBA 09/2021 - 01/2015
2	GastrinsIBA 09/2021 - 01/2020
2	AlbuminsIBA 01/2021 - 04/2007
2	Transaminases (Aminotransferases)IBA 12/2020 - 05/2012
2	MTOR InhibitorsIBA 11/2020 - 05/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 08/2008
2	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 10/2019 - 01/2019
2	derazantinibIBA 10/2019 - 01/2019
2	DNA (Deoxyribonucleic Acid)IBA 08/2019 - 04/2008
2	Formaldehyde (Formol)FDA Link 01/2019 - 11/2008
2	Peptide Receptors (Peptide Receptor)IBA 01/2019 - 01/2015
2	Fetal Proteins (Fetoprotein)IBA 01/2018 - 01/2018
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2018 - 05/2012
2	Succinate Dehydrogenase (Fumarate Reductase)IBA 09/2017 - 08/2012
2	Antiviral Agents (Antivirals)IBA 01/2017 - 09/2015
2	Interferon-alpha (Interferon Alfa)IBA 05/2010 - 12/2006
2	beta CateninIBA 05/2010 - 04/2007
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2008 - 07/2008
2	sarcoma glycoprotein gp96 rejection antigensIBA 05/2005 - 10/2003
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 03/2004 - 08/2003
2	Peptides (Polypeptides)IBA 10/2003 - 08/2003

Therapy/Procedure

53	Liver Transplantation 01/2022 - 05/2002
37	Therapeutics 01/2022 - 07/2008
13	Transplantation 01/2021 - 03/2006
10	Drug Therapy (Chemotherapy) 08/2021 - 04/2005
9	Hepatectomy 10/2021 - 04/2010
6	Immunotherapy 01/2022 - 01/2018
4	Neoadjuvant Therapy 02/2022 - 07/2015
4	Radiofrequency Ablation 01/2017 - 11/2004
3	Gastrectomy 05/2022 - 05/2010
3	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 01/2017
2	Microspheres (Microsphere) 02/2022 - 05/2017
2	Duration of Therapy 12/2021 - 04/2019
2	Precision Medicine 01/2021 - 01/2021
2	Contraindications 01/2020 - 01/2018
2	Aftercare (After-Treatment) 01/2020 - 12/2018
2	Cytoreduction Surgical Procedures 01/2018 - 09/2002
2	Chemoprevention 05/2016 - 12/2006